Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now?
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now?
The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now? Am J Kidney Dis. 2008 Dec; 52(6 Suppl):S5-13.
View in:
PubMed
subject areas
Anemia
Dose-Response Relationship, Drug
Epoetin Alfa
Erythropoietin
Hematinics
Hemoglobins
Humans
Kidney Failure, Chronic
Medicaid
Medicare
Recombinant Proteins
United States
United States Food and Drug Administration
authors with profiles
Ajaypal Singh